Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Metabolic Medicine

Diagnosis & Differentiating from PKU

At a Glance

DNAJC12 deficiency can resemble PKU because both raise phenylalanine on newborn screening. Doctors combine urine pterin and DHPR tests with genetic testing; a response to BH4 does not rule it out, and a spinal tap may be considered in selected cases.

The path to a diagnosis of DNAJC12 deficiency often begins with a phone call after a newborn screening test. Because this condition is so rare and was only recently discovered, the diagnostic journey can sometimes be confusing, with the condition masquerading as more common disorders like PKU (Phenylketonuria).

Getting to the right answer requires a step-by-step process to distinguish between several different causes of high phenylalanine.

Why It “Looks Like” PKU

When a baby is born, a small prick of blood is taken to screen for various conditions. Most of these screens look for high levels of an amino acid called phenylalanine (a condition called hyperphenylalaninemia or HPA).

In standard PKU, the high levels are caused by a “broken machine” (the PAH enzyme) [1]. In DNAJC12 deficiency, the PAH enzyme itself is intact, but the “mechanic” (the DNAJC12 protein) is missing [2]. Because both problems lead to the same result—elevated phenylalanine in the blood—the newborn screen flags both conditions the exact same way [3].

The BH4 “Loading Test” Trap

One of the first things a metabolic specialist may do is a BH4 loading test (or sapropterin challenge). They give a dose of BH4 to see if blood phenylalanine levels drop.

In many children with DNAJC12 deficiency, the levels do drop—sometimes by 30% or more [4][5]. In the past, this “pass” was taken as proof that the child had either a BH4 synthesis deficiency or BH4-responsive PKU. However, we now know that DNAJC12-deficient patients can respond to this test [5]. Relying on this test alone without further biochemical or genetic evaluation can lead to an incorrect diagnosis.

The Diagnostic Checklist

To be certain of a DNAJC12 diagnosis, your medical team must look at several pieces of evidence. No single test establishes the diagnosis.

1. Evaluating Other Causes

Doctors will check for indicators of more common disorders. In DNAJC12 deficiency, these tests typically show normal patterns:

  • Urine Pterins: These are chemicals related to BH4. They are generally normal in DNAJC12 deficiency but show specific abnormal patterns in BH4 disorders [1][6].
  • DHPR Activity: This is an enzyme test often done via a blood spot. It is normal in DNAJC12 deficiency [1].

2. Genetic Testing (The Key Evidence)

A diagnosis generally depends on finding two disease-causing variants (pathogenic or likely pathogenic) in the DNAJC12 gene [4]. Note that a “variant of uncertain significance” (VUS) does not confirm the disorder on its own.

  • Important Note on Deletions: Standard genetic tests (like a “whole exome”) can sometimes miss large chunks of missing DNA called deletions depending on the laboratory platform [7]. At least one case was missed initially because the child had a 6.9-kb deletion that standard analysis didn’t detect [7]. Parents should explicitly ask if “copy-number analysis” (deletion and duplication testing) was performed.

3. CSF Neurotransmitter Testing (Selected Cases)

Because DNAJC12 affects brain chemicals, your doctor may recommend a lumbar puncture (spinal tap) to check the cerebrospinal fluid (CSF). This is an invasive procedure and may be considered selectively, rather than routinely for every patient. It looks for indirect metabolites:

  • HVA (Homovanillic Acid): A metabolite of dopamine [1].
  • 5-HIAA (5-Hydroxyindoleacetic Acid): A metabolite of serotonin [1].

In children with DNAJC12 deficiency, these markers are typically low, though results must be interpreted using age-specific reference ranges [8][9].

Typical Diagnostic Patterns

(Note: These are typical patterns that require specialist interpretation, not absolute diagnostic rules. Other secondary causes of HPA exist).

  • Classic PKU: High Phenylalanine | Normal Urine Pterins/DHPR | Pathogenic PAH variants
  • BH4 Disorders: High Phenylalanine | Abnormal Urine Pterins/DHPR (depends on disorder) | Positive BH4 response often seen | Pathogenic variants in PTS, GCH1, etc.
  • DNAJC12 Deficiency: High Phenylalanine | Normal Urine Pterins/DHPR | Positive BH4 response often seen | Low CSF HVA/5-HIAA | Pathogenic DNAJC12 variants

Common questions in this guide

How can doctors tell DNAJC12 deficiency apart from PKU?
Both conditions can cause high phenylalanine on newborn screening. Doctors compare urine pterin and DHPR results, review genetic testing, and sometimes examine cerebrospinal fluid neurotransmitter metabolites; PKU is associated with PAH variants, while DNAJC12 deficiency usually requires two disease-causing DNAJC12 variants. No single test is enough.
Can a response to a BH4 test rule out DNAJC12 deficiency?
No. Some children with DNAJC12 deficiency show a meaningful fall in phenylalanine after a BH4 loading test or sapropterin challenge. The result must be interpreted with urine, enzyme, and genetic testing rather than used alone.
What genetic testing is needed to confirm DNAJC12 deficiency?
Testing generally looks for two pathogenic or likely pathogenic variants in DNAJC12. A variant of uncertain significance does not confirm the diagnosis. Ask whether copy-number analysis for deletions and duplications was included, because standard sequencing or exome testing can miss some large deletions.
Does every child with suspected DNAJC12 deficiency need a lumbar puncture?
Not necessarily. Doctors may use a lumbar puncture selectively to measure HVA and 5-HIAA in cerebrospinal fluid, and these results are interpreted using age-specific ranges. The decision should weigh the potential information against the invasiveness of the procedure.
What tests are checked after a newborn screen shows high phenylalanine?
The evaluation may include urine pterins and DHPR activity to look for BH4 disorders, along with genetic testing for PAH and DNAJC12 variants. A BH4 loading test may be performed, but a positive response does not by itself identify the cause. A metabolic specialist interprets the full pattern.

Get notified when new evidence is published on Hyperphenylalaninemia due to DNAJC12 deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (9)
  1. 1

    Developmental delay and non-phenylketonuria (PKU) hyperphenylalaninemia in DNAJC12 deficiency: Case and approach.

    Wong RSH, Mohammad S, Parayil Sankaran B, et al.

    Brain & development 2023; (45(9)):523-531 doi:10.1016/j.braindev.2023.04.004.

    PMID: 37156708
  2. 2

    Biallelic Mutations in DNAJC12 Cause Hyperphenylalaninemia, Dystonia, and Intellectual Disability.

    Anikster Y, Haack TB, Vilboux T, et al.

    American journal of human genetics 2017; (100(2)):257-266 doi:10.1016/j.ajhg.2017.01.002.

    PMID: 28132689
  3. 3

    DNAJC12 Stabilizes Phenylalanine Hydroxylase and Facilitates Its Substrate-Dependent Activation.

    Tai MDS, Kråkenes TA, Gamiz-Arco G, et al.

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2026; (40(14)):e72151 doi:10.1096/fj.202504522RR.

    PMID: 42497073
  4. 4

    DNAJC12 deficiency: A new strategy in the diagnosis of hyperphenylalaninemias.

    Blau N, Martinez A, Hoffmann GF, Thöny B

    Molecular genetics and metabolism 2018; (123(1)):1-5 doi:10.1016/j.ymgme.2017.11.005.

    PMID: 29174366
  5. 5

    Phenylalanine and tyrosine metabolism in DNAJC12 deficiency: A comparison between inherited hyperphenylalaninemias and healthy subjects.

    Porta F, Ponzone A, Spada M

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2020; (28()):77-80 doi:10.1016/j.ejpn.2020.07.011.

    PMID: 32800687
  6. 6

    DNACJ12 deficiency in patients with unexplained hyperphenylalaninemia: two new patients and a novel variant.

    Çıkı K, Yıldız Y, Yücel Yılmaz D, et al.

    Metabolic brain disease 2021; (36(6)):1405-1410 doi:10.1007/s11011-021-00753-0.

    PMID: 34014443
  7. 7

    Beneficial Effect of BH4 Treatment in a 15-Year-Old Boy with Biallelic Mutations in DNAJC12.

    de Sain-van der Velden MGM, Kuper WFE, Kuijper MA, et al.

    JIMD reports 2018; (42()):99-103 doi:10.1007/8904_2017_86.

    PMID: 29380259
  8. 8

    A rare cause of hyperphenylalaninemia: four cases from a single family with DNAJC12 deficiency.

    Gunes D, Senturk L

    Journal of pediatric endocrinology & metabolism : JPEM 2023; (36(8)):791-797 doi:10.1515/jpem-2023-0049.

    PMID: 37283250
  9. 9

    Heterogeneous clinical spectrum of DNAJC12-deficient hyperphenylalaninemia: from attention deficit to severe dystonia and intellectual disability.

    van Spronsen FJ, Himmelreich N, Rüfenacht V, et al.

    Journal of medical genetics 2017; doi:10.1136/jmedgenet-2017-104875.

    PMID: 28794131

This page is for informational purposes only and does not constitute medical advice. A metabolic or genetics specialist should interpret your child's results and discuss the benefits and risks of tests such as a lumbar puncture.